NSE: CAPLIPOINT

Caplin Point Laboratories Ltd Share Price

Company information and financial fundamentals for Caplin Point Laboratories Ltd, alongside its latest NSE share price.

Last price₹2,352.70-0.43% today · prev close ₹2,362.80
SectorHealthcare

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations.[1]

Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals · NSE symbol: CAPLIPOINT

Company fundamentals

Market Cap₹ 17,976 Cr.
Current Price₹ 2,365
High / Low₹ 2,991 / 1,500
Stock P/E27.0
Book Value₹ 443
Dividend Yield0.33 %
ROCE24.2 %
ROE20.9 %
Face Value₹ 2.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-03); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales453459483493502510534543600610
Expenses308307318331334332345353396397
Operating Profit145152165162168178189190204213
OPM %32%33%34%33%33%35%35%35%34%35%
Other Income17192131262330342834
Interest0000000000
Depreciation16161716171618191922
Profit before tax146154168177177184201204213225
Tax %17%19%22%21%18%18%20%19%19%20%
Net Profit121125131140145151160166173179
EPS in Rs16.0116.3117.2118.2818.7620.1020.3221.5622.3823.27
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5406498631,0611,2691,4671,6941,9372,1872,287
Expenses3454176037328741,0251,1421,2871,4221,491
Operating Profit195232260329395442552651765797
OPM %36%36%30%31%31%30%33%34%35%35%
Other Income1319412338556692111126
Interest1102111111
Depreciation19233237474553667378
Profit before tax188227269314386451564677803844
Tax %23%22%20%20%20%16%18%20%19%—
Net Profit145177215251308377461541650678
EPS in Rs19.1523.3528.4232.0339.5649.5760.1970.5684.3687.53
Dividend Payout %10%9%9%9%10%9%8%8%9%—

Compounded growth

Compounded Sales Growth10 Years 25%5 Years 16%3 Years 14%TTM 15%
Compounded Profit Growth10 Years 30%5 Years 21%3 Years 19%TTM 18%
Stock Price CAGR10 Years 20%5 Years 23%3 Years 30%1 Year 16%
Return on Equity10 Years 25%5 Years 23%3 Years 22%Last Year 21%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital15151515151515151515
Reserves2103495828589541,2521,6492,0842,6193,355
Borrowings1136113235219222219222221
Other Liabilities133136109139159250305380352446
Total Liabilities3585007431,1261,3641,7362,1912,6983,2084,038
Fixed Assets152169227272305287280453546580
CWIP31510201418221117144234
Investments174770611189281376590859
Other Assets1862694367721,0331,3431,4101,7531,9282,365
Total Assets3585007431,1261,3641,7362,1912,6983,2084,038

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity68668345269337271318432523
Cash from Investing Activity-36-69-100-54-30-377-216-319-333-582
Cash from Financing Activity-7-129080-24-41-28-38-38-46
Net Cash Flow25-147370215-8127-3961-105
Free Cash Flow431818-3219524678173241275
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit73%53%54%38%102%106%81%77%86%87%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days30859097969198117119138
Inventory Days444447210139149159183159181
Days Payable15514476576810284116103125
Cash Conversion Cycle-81-1661251166138173184175194
Working Capital Days-2947104167145165144166174199
ROCE %68%63%45%33%28%28%26%26%26%24%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters70.56%70.56%70.56%70.56%70.56%70.57%70.57%70.57%70.57%70.57%
FIIs3.38%3.71%4.86%5.73%6.16%6.51%6.58%6.15%5.76%5.72%
DIIs1.49%1.83%2.11%2.00%2.22%2.10%2.05%2.14%2.49%2.20%
Public24.59%23.93%22.48%21.72%21.06%20.82%20.81%21.14%21.19%21.52%
No. of Shareholders80,41196,12392,70296,38794,16993,75393,70593,89694,3851,03,386

Exchange disclosures

Next results date

Caplin Point Laboratories Ltd has a board meeting for financial results listed on 2026-11-12. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

Compare CAPLIPOINT with APOLLOHOSP →

Wondering what to do with Caplin Point Laboratories Ltd?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about CAPLIPOINT →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NSE

Apollo HospitalsNSE: APOLLOHOSPCiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Frequently asked questions

What is the NSE symbol for Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd trades on the NSE under the symbol CAPLIPOINT.

Where is Caplin Point Laboratories Ltd listed?

Caplin Point Laboratories Ltd is listed on the National Stock Exchange of India (NSE) under the symbol CAPLIPOINT. It is not part of the NIFTY 50 or NIFTY 500 lists this site tracks.

Should I buy Caplin Point Laboratories Ltd shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.